Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter (QFR120385USNO)

Observations

Q2 2026: 20,490
Updated: Sep 8, 2026 9:12 AM CDT
Next Release Date: Dec 7, 2026
Q2 2026:  20,490  
Q1 2026:  12,828  
Q4 2025:  22,583  
Q3 2025:  13,290  
Q2 2025:  19,924  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter [QFR120385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR120385USNO, .

Release Tables

Quarterly Financial Report

Related Data and Content

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

retained earnings Dividends Medicines Pharmaceuticals Cash Quarterly Financial Report Chemicals Nondurable Goods Finance Earnings Corporate Goods Manufacturing Industry Census Quarterly Nation Public Domain: Citation Requested United States of America Not Seasonally Adjusted

Back to Top

Subscribe to the FRED newsletter

Follow us

 

Need Help?

Questions or Comments
FRED Help
Legal
Privacy Notice & Policy